NL44885C - - Google Patents

Info

Publication number
NL44885C
NL44885C NL44885DA NL44885C NL 44885 C NL44885 C NL 44885C NL 44885D A NL44885D A NL 44885DA NL 44885 C NL44885 C NL 44885C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL44885C publication Critical patent/NL44885C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/15Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL44885D 1935-11-09 NL44885C (US06262066-20010717-C00315.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE484600X 1935-11-09

Publications (1)

Publication Number Publication Date
NL44885C true NL44885C (US06262066-20010717-C00315.png)

Family

ID=6543150

Family Applications (1)

Application Number Title Priority Date Filing Date
NL44885D NL44885C (US06262066-20010717-C00315.png) 1935-11-09

Country Status (3)

Country Link
US (1) US2149005A (US06262066-20010717-C00315.png)
GB (1) GB484600A (US06262066-20010717-C00315.png)
NL (1) NL44885C (US06262066-20010717-C00315.png)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899361A (en) * 1959-08-11 Certificate of correction
US2457188A (en) * 1945-05-24 1948-12-28 Americaine Inc Benzocaine solution
US2469618A (en) * 1945-09-21 1949-05-10 Eaton Lab Inc Vaginal suppository
US2498374A (en) * 1945-10-05 1950-02-21 Francis E Martin Method and article for treatment of mammary glands
US2538127A (en) * 1948-02-26 1951-01-16 Searle & Co Medicated suppositories and bases therefor
US2584166A (en) * 1948-05-25 1952-02-05 Ayerst Mckenna & Harrison Suppository
US2540253A (en) * 1949-02-08 1951-02-06 Merck & Co Inc Granulation process
US2681297A (en) * 1950-10-31 1954-06-15 Mattox And Moore Inc Veterinary estrogen composition and administration method
US2605209A (en) * 1950-11-03 1952-07-29 Lilly Co Eli Solutions of barbituric compounds
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
US2762746A (en) * 1952-11-14 1956-09-11 American Home Prod Composition for combating malaria and process of making same
US2791530A (en) * 1953-08-31 1957-05-07 Abbott Lab Stabilized fumagillin compositions
US2890983A (en) * 1956-07-31 1959-06-16 Monot Pierre Louis Victor Excipient
US2949402A (en) * 1958-04-16 1960-08-16 American Cyanamid Co Tablet coating
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3163576A (en) * 1961-06-12 1964-12-29 Olin Mathieson Suppository base comprising glycerin and a diester of polyethylene glycol
US3149038A (en) * 1961-09-05 1964-09-15 Dow Chemical Co Thin film coating for tablets and the like and method of coating
BE636865A (US06262066-20010717-C00315.png) * 1962-08-31
US3511914A (en) * 1967-01-31 1970-05-12 Schering Corp Throat lozenge vehicle
BE756975A (fr) * 1970-06-09 1971-04-02 Merck & Co Inc Suppositoires
US3826232A (en) * 1970-09-18 1974-07-30 Pet Chem Inc Composition and method for the control of fleas on domesticated animals
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
BE789726A (fr) * 1971-10-06 1973-04-05 Merck & Co Inc Suppositoires a l'indomethacine
DE2213604C2 (de) * 1972-03-21 1975-08-14 Merz & Co, 6000 Frankfurt Vaginalzäpfchen zur Empfängnisverhütung
USRE29102E (en) * 1972-03-21 1977-01-04 Merz & Co. Contraception agent
JPS4950119A (US06262066-20010717-C00315.png) * 1972-09-21 1974-05-15
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
ES8305559A1 (es) * 1981-04-29 1983-04-16 Int Spike Un procedimiento para preparar un producto pesticida sistemico de liberacion prolongada.
GB2159052A (en) * 1984-05-18 1985-11-27 Bernard John Roberts Artificial mucus material
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier

Also Published As

Publication number Publication date
US2149005A (en) 1939-02-28
GB484600A (en) 1938-05-09

Similar Documents

Publication Publication Date Title
BE402725A (US06262066-20010717-C00315.png)
BE408712A (US06262066-20010717-C00315.png)
BE407519A (US06262066-20010717-C00315.png)
BE405881A (US06262066-20010717-C00315.png)
BE407131A (US06262066-20010717-C00315.png)
BE407302A (US06262066-20010717-C00315.png)
BE407388A (US06262066-20010717-C00315.png)
BE407411A (US06262066-20010717-C00315.png)
BE407478A (US06262066-20010717-C00315.png)
BE407487A (US06262066-20010717-C00315.png)
BE407491A (US06262066-20010717-C00315.png)
BE407622A (US06262066-20010717-C00315.png)
BE407630A (US06262066-20010717-C00315.png)
BE407652A (US06262066-20010717-C00315.png)
BE407653A (US06262066-20010717-C00315.png)
BE407703A (US06262066-20010717-C00315.png)
BE407774A (US06262066-20010717-C00315.png)
BE407804A (US06262066-20010717-C00315.png)
BE407883A (US06262066-20010717-C00315.png)
BE408024A (US06262066-20010717-C00315.png)
BE408083A (US06262066-20010717-C00315.png)
BE408090A (US06262066-20010717-C00315.png)
BE408096A (US06262066-20010717-C00315.png)
BE408282A (US06262066-20010717-C00315.png)
BE408330A (US06262066-20010717-C00315.png)